India, Sept. 1 -- Pivot Path recently secured an investment of Rs 100 crore from Ascent Capital. What are your strategic priorities for deploying this capital, and how will it support the company's next phase of growth?

The investment is concentrated where the regulated workload is heaviest and the manual effort least defensible. In pharmacovigilance, that is NovaVigil: extraction, data entry etc. consume qualified people on work that does not need their judgement. In quality and compliance, it is NoteIQ, because validation and controlled documents are where a change gets stuck for months.

AnomIQ, because audit-trail review is done at defined intervals by sampling, rather than through continuous real-time monitoring. Issues may remain u...